abstract |
This invention relates to polypeptides, including variants of inhibin, and related therapeutics and compositions. Further, the invention relates to the use in the treatment or prevention of conditions associated with reduced levels of inhibin-mediated signalling. Specifically, the invention relates to inhibins and inhibin subunits with one or more mutations of modifications to increase the activity and/or reduce the formation of activin. |